779 related articles for article (PubMed ID: 14568906)
1. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model.
Namba T; Koike H; Murakami K; Aoki M; Makino H; Hashiya N; Ogihara T; Kaneda Y; Kohno M; Morishita R
Circulation; 2003 Nov; 108(18):2250-7. PubMed ID: 14568906
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
[TBL] [Abstract][Full Text] [Related]
3. Enhanced therapeutic angiogenesis by cotransfection of prostacyclin synthase gene or optimization of intramuscular injection of naked plasmid DNA.
Hiraoka K; Koike H; Yamamoto S; Tomita N; Yokoyama C; Tanabe T; Aikou T; Ogihara T; Kaneda Y; Morishita R
Circulation; 2003 Nov; 108(21):2689-96. PubMed ID: 14568901
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
[TBL] [Abstract][Full Text] [Related]
5. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.
Hashiya N; Jo N; Aoki M; Matsumoto K; Nakamura T; Sato Y; Ogata N; Ogihara T; Kaneda Y; Morishita R
Circulation; 2004 Jun; 109(24):3035-41. PubMed ID: 15173033
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of endothelium nitric oxide synthase reverses the diminished vasorelaxation in the hindlimb vasculature in ischemic heart failure in vivo.
Gaballa MA; Goldman S
J Mol Cell Cardiol; 1999 Jun; 31(6):1243-52. PubMed ID: 10371698
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-B promotes in vivo angiogenesis.
Silvestre JS; Tamarat R; Ebrahimian TG; Le-Roux A; Clergue M; Emmanuel F; Duriez M; Schwartz B; Branellec D; Lévy BI
Circ Res; 2003 Jul; 93(2):114-23. PubMed ID: 12805240
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer of endothelial nitric oxide isoform decreases rat hindlimb vascular resistance in vivo.
Gaballa MA; Goldman S
Hum Gene Ther; 2000 Aug; 11(12):1637-46. PubMed ID: 10954898
[TBL] [Abstract][Full Text] [Related]
10. Hindlimb claudication reflects impaired nitric oxide-dependent revascularization after ischemia.
Luque Contreras D; Jiménez Estrada I; Martínez Fong D; Segura B; Guadarrama JC; Paniagua Sierra R; Vargas Robles H; Rios A; Escalante B
Vascul Pharmacol; 2007 Jan; 46(1):10-5. PubMed ID: 17011243
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
Gao L; Yu DM
Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
[TBL] [Abstract][Full Text] [Related]
13. Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs.
Silvestre JS; Kamsu-Kom N; Clergue M; Duriez M; Lévy BI
J Pharmacol Exp Ther; 2002 Dec; 303(3):1038-43. PubMed ID: 12438525
[TBL] [Abstract][Full Text] [Related]
14. Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia.
Pfosser A; Thalgott M; Büttner K; Brouet A; Feron O; Boekstegers P; Kupatt C
Cardiovasc Res; 2005 Feb; 65(3):728-36. PubMed ID: 15664400
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study on treatment of acute limb ischemia with vascular endothelial growth factor-121 gene transfer].
Zheng ZH; Xu L; Fan XH
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2004 Mar; 18(2):142-5. PubMed ID: 15065417
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 is important for nitric oxide-mediated angiogenesis in fibrin gels with human umbilical vein endothelial cells.
Pan YM; Yao YZ; Zhu ZH; Sun XT; Qiu YD; Ding YT
Acta Pharmacol Sin; 2006 Dec; 27(12):1567-74. PubMed ID: 17112410
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism.
Schgoer W; Theurl M; Jeschke J; Beer AG; Albrecht K; Gander R; Rong S; Vasiljevic D; Egger M; Wolf AM; Frauscher S; Koller B; Tancevski I; Patsch JR; Schratzberger P; Piza-Katzer H; Ritsch A; Bahlmann FH; Fischer-Colbrie R; Wolf D; Kirchmair R
Circ Res; 2009 Nov; 105(10):994-1002. PubMed ID: 19797703
[TBL] [Abstract][Full Text] [Related]
18. Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.
Qian HS; Liu P; Huw LY; Orme A; Halks-Miller M; Hill SM; Jin F; Kretschmer P; Blasko E; Cashion L; Szymanski P; Vergona R; Harkins R; Yu J; Sessa WC; Dole WP; Rubanyi GM; Kauser K
Gene Ther; 2006 Sep; 13(18):1342-50. PubMed ID: 16642030
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells.
Józkowicz A; Pankiewicz J; Dulak J; Partyka L; Wybrańska I; Huk I; Dembińska-Kieć A
Acta Biochim Pol; 1999; 46(3):703-15. PubMed ID: 10698278
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model.
Urano T; Ito Y; Akao M; Sawa T; Miyata K; Tabata M; Morisada T; Hato T; Yano M; Kadomatsu T; Yasunaga K; Shibata R; Murohara T; Akaike T; Tanihara H; Suda T; Oike Y
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):827-34. PubMed ID: 18258819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
